Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : GLGC Gene Logic -- Ignore unavailable to you. Want to Upgrade?

To: Steve Lokness who wrote (52)	6/1/1999 1:29:00 AM
From: Dave Kahn	Read Replies (1) \| Respond to of 360

I dont understand lull??? storm??? Please ? Dave

To: Steve Lokness who wrote (52)	7/2/1999 6:04:00 PM
From: Steve Push	Respond to of 360

Steve, Re. your question on diagnostics, we are not currently anticipating the use of the Flow-thru Chip(TM) for diagnostic purposes. The two uses we currently anticipate are screening for new drug leads and screening leads for possible toxicity. At present the chip is still in development, and we don't know if it will be feasible for either application. There may be potential to develop it for additional applications, but we have not fully explored these possibilities yet. Steve Push VP, Corporate Communications Gene Logic Inc. genelogic.com